Clinical trials present a new approach using immunotherapy

After 40 years of treating metastatic bladder cancer with chemotherapy as a primary treatment, scientists now present a new approach using immunotherapy combinations. The results of two studies have been presented at the European Society for Medical Oncology (ESMO) conference in Madrid. The outcomes of these studies could revolutionize the landscape of bladder cancer treatment.

CAR T-Cell Therapy: What It Is & How It Works

What is neoantigen-based therapy?

Categorization of clinical trials involving immunological approaches

Approach ImmunoSep

Results of the KELLY trial

Scientists engineer potent immune cells for 'off-the-shelf' cancer immunotherapy

A New Biomarker for Response to Checkpoint Inhibitors - NCI

Cancer vaccines: the next immunotherapy frontier

Frontiers Clinical cancer immunotherapy: Current progress and prospects

Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy, Journal of Hematology & Oncology

Not a cure, but an extension: How immunotherapy works for advanced lung cancer, Cancer, Lungs

Future of cancer treatment: what will therapy look like in 2034?

In cancer treatment, new evidence that the neighborhood matters

Breakthroughs in Pancreatic Cancer Treatment

How Oral Cancer Is Treated

Radiation Therapy with Cancer Treatment